LENZ Therapeutics, Inc.LENZNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +232.20% | +231.76% | +483.47% | +9.65% | +5.04% |
| Weighted Average Shares Diluted Growth | +232.20% | +231.76% | +483.47% | +9.65% | +5.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +143.02% | +205.93% | -7.39% | +7.25% | -5.94% |
| Book Value per Share Growth | +0.00% | +0.00% | -83.39% | -2.44% | -14.24% |
| Debt Growth | +338.33% | +319.76% | +100.68% | -38.21% | -70.79% |
| R&D Expense Growth | -62.06% | -69.96% | -44.79% | +30.47% | -41.23% |
| SG&A Expenses Growth | +126.98% | +71.59% | +100.20% | +72.76% | +323.02% |